Short answer
Outset Medical, Inc. (OM) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $28M (down 6.3% year over year) with net income of −$19M.
Q1 2026 key financials · XBRL
- Revenue
- $28M
- −6.3% YoY
- Net income
- −$19M
- +26.4% YoY
- Operating margin
- -60.7%
- Gross margin
- 43.4%
- EPS (diluted)
- −$1.03
- +71.9% YoY
Source: XBRL data from the Outset Medical, Inc. (OM) Q1 2026 10-Q on SEC EDGAR. USD.
Outset Medical, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $27.9M, down 6% YoY from $29.8M; product revenue fell 13% to $18.6M
- Gross margin 43.4% vs 37.2% YoY; gross profit $12.1M vs $11.1M
- Service and other revenue rose 10% to $9.3M, strongest reported revenue category
- Operating cash flow use $12.8M vs $25.7M; cash, restricted cash and investments $160.5M
- Near-term operating losses expected; customer purchase deferrals, tariffs and cautious capital spending remain headwinds
Risk Factors
- No risk-factors section provided; submitted text covers Items 2–6 and signatures only
- No newly added risk factor identifiable from the provided filing text
- No material regulatory, legal, operational, competitive, market, or financial risk disclosed in the provided text
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Outset Medical, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.